486 related articles for article (PubMed ID: 16497445)
1. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review.
Sahli R; Christ ER; Seiler R; Kappeler A; Vajtai I
Pathol Res Pract; 2006; 202(6):457-64. PubMed ID: 16497445
[TBL] [Abstract][Full Text] [Related]
2. Crooke's hyalinization in silent corticotroph adenoma: report of two cases.
Roncaroli F; Faustini-Fustini M; Mauri F; Asioli S; Frank G
Endocr Pathol; 2002; 13(3):245-9. PubMed ID: 12446925
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic correlates of giant pituitary adenomas.
Chacko G; Chacko AG; Lombardero M; Mani S; Seshadri MS; Kovacs K; Scheithauer BW
J Clin Neurosci; 2009 May; 16(5):660-5. PubMed ID: 19285407
[TBL] [Abstract][Full Text] [Related]
4. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
5. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
6. A spectrum of behaviour in silent corticotroph pituitary adenomas.
Baldeweg SE; Pollock JR; Powell M; Ahlquist J
Br J Neurosurg; 2005 Feb; 19(1):38-42. PubMed ID: 16147581
[TBL] [Abstract][Full Text] [Related]
7. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
8. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
9. Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia.
Haap M; Gallwitz B; Meyermann R; Mittelbronn M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):289-93. PubMed ID: 19085700
[TBL] [Abstract][Full Text] [Related]
10. Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence.
Psaras T; Honegger J; Buslei R; Saeger W; Klein D; Capper D; Meyermann R; Mittelbronn M
Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):610-5. PubMed ID: 17943697
[TBL] [Abstract][Full Text] [Related]
11. Silent corticotroph adenomas have unique recurrence characteristics compared with other nonfunctioning pituitary adenomas.
Cho HY; Cho SW; Kim SW; Shin CS; Park KS; Kim SY
Clin Endocrinol (Oxf); 2010 May; 72(5):648-53. PubMed ID: 19650787
[TBL] [Abstract][Full Text] [Related]
12. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
[TBL] [Abstract][Full Text] [Related]
13. "Silent"corticotropinoma.
Pawlikowski M; Kunert-Radek J; Radek M
Neuro Endocrinol Lett; 2008 Jun; 29(3):347-50. PubMed ID: 18580839
[TBL] [Abstract][Full Text] [Related]
14. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
15. Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.
Sumislawski P; Huckhagel T; Krajewski KL; Aberle J; Saeger W; Flitsch J; Rotermund R
Sci Rep; 2023 Feb; 13(1):2468. PubMed ID: 36774403
[TBL] [Abstract][Full Text] [Related]
16. Adrenocorticotropic hormone cells and immunoreactive beta-endorphin cells in the human pituitary gland: normal and pathologic conditions studied by the peroxidase-labeled antibody method.
Osamura RY; Watanabe K; Nakai Y; Imura H
Am J Pathol; 1980 Apr; 99(1):105-24. PubMed ID: 6244739
[TBL] [Abstract][Full Text] [Related]
17. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility.
Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB
J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609
[TBL] [Abstract][Full Text] [Related]
18. Pituitary adenomas that produce adrenocorticotropic hormone and alpha-subunit: clinicopathological, immunohistochemical, ultrastructural, and immunoelectron microscopic studies in nine cases.
Berg KK; Scheithauer BW; Felix I; Kovacs K; Horvath E; Klee GG; Laws ER
Neurosurgery; 1990 Mar; 26(3):397-403. PubMed ID: 1690866
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
[TBL] [Abstract][Full Text] [Related]
20. Multiple cellular forms of corticotrophs in surgically removed pituitary adenomas and periadenomatous tissue in Cushing's disease.
Martin R; Cetin Y; Fehm HL; Fahlbusch R; Voigt KH
Am J Pathol; 1982 Mar; 106(3):332-41. PubMed ID: 6278938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
